1-3 of 3
Yu-Jui Ho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia

Scott Evan Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, Yu-Jui Ho, John P Morris IV, Varun Narendra, Chi-Chao Chen, Benjamin T Jackson, Jossie J Yashinskie, Riccardo Mezzadra, Tessa I Devine, Valentin J. A. Barthet, Michelle Saoi, Timour Baslan, Sha Tian, Zohar Sachs, Lydia WS Finley, Justin R Cross, Scott W Lowe
Journal: Blood
Blood blood.2024025245.
https://doi.org/10.1182/blood.2024025245
Published: 2024
Includes: Supplemental data
Journal Articles

Ogdh Is a Genetic Vulnerability and Therapeutic Target in Acute Myeloid Leukemia

Scott E Millman, Almudena Chaves-Perez, John P Morris, IV, Chi-Chao Chen, Yu-Jui Ho, Sudha Janaki Raman, Jossie J Yashinskie, Riccardo Mezzadra, Varun Narendra, Sha Tian, Alexandra Wuest, Wei Luan, Justin R Cross, Lydia WS Finley, Scott W Lowe
Journal: Blood
Blood (2022) 140 (Supplement 1): 5846–5847.
https://doi.org/10.1182/blood-2022-166414
Published: 2022
Journal Articles

Calibrated CAR Activation Potential Directs Alternative T Cell Fates and Therapeutic Potency

Judith Feucht, MD, Jie Sun, PhD, Justin Eyquem, PhD, Yu-Jui Ho, PhD, Zeguo Zhao, PhD, Josef Leibold, MD, Anton Dobrin, Annalisa Cabriolu, PhD, Mohamad Hamieh, PhD, Michel Sadelain, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1412.
https://doi.org/10.1182/blood-2018-99-117698
Published: 2018